S&P 500
(0.16%) 5 469.00 points
Dow Jones
(0.19%) 39 192 points
Nasdaq
(0.54%) 17 828 points
Oil
(1.86%) $83.06
Gas
(-3.81%) $2.50
Gold
(-0.08%) $2 337.70
Silver
(0.12%) $29.60
Platinum
(-1.29%) $989.00
USD/EUR
(-0.15%) $0.932
USD/NOK
(-0.13%) $10.66
USD/GBP
(0.00%) $0.791
USD/RUB
(1.05%) $86.62

Q1/2024

Generated By Getagraph.com: 2024-04-30

Streamline Health [STRM] 7.42% $ 0.495
Биржа: NASDAQ Сектор: Healthcare Промышленность: Health Information Services

Streamline Health Solutions Inc: First Quarter of Fiscal 2024 Financial Results

Management Commentary

The earnings call was led by Jacob Goldberger, Vice President of Finance, accompanied by Ben Stilwill, President and Chief Executive Officer, and BJ Reeves, Chief Financial Officer. During the call, management discussed the significant progress made during the first quarter of fiscal 2024, enhancing the value provided to the healthcare revenue cycle through product improvements and new client acquisitions. They expressed confidence in achieving an adjusted EBITDA breakeven run rate in the second half of the fiscal year due to improved operational efficiency, product functionality, and additional client partnerships.

Financial Performance Overview

Streamline Health Solutions Inc. reported a total revenue of $4.3M for the first quarter of fiscal 2024, compared to $5.3M in the same period of fiscal 2023. This change was primarily due to previously announced client non-renewals, offset by successful new SaaS contracts. Pro forma SaaS revenue grew 22% after excluding revenues from the non-renewal client, indicating robust underlying growth in the company’s core SaaS business.

The company’s operating expenses decreased to $6.6M from $8.3M in the first quarter of the previous fiscal year. This reduction resulted from a strategic restructuring that reduced SG&A and R&D costs, professional fees, and software license costs.

Despite the lower revenue, the company’s net loss declined slightly to $2.7M from $2.9M in the first quarter of fiscal 2023, thanks to cost-saving measures. Adjusted EBITDA showed a significant improvement with a loss of $0.7M compared to a loss of $1.3M in the previous year's first quarter.

Balance Sheet

As of April 30, 2024, Streamline Health Solutions had $4M in cash, up from $3.2M as of January 31, 2024. Total debt stood at $12.5M, with no balance on the company’s revolving credit facility.

The company's total assets were $41.7M with $24.42M in total liabilities, translating to a total stockholders' equity of $17.3M. Notable line items included $3.98M in cash and short-term investments, $4.71M in net receivables, and $24.94M in goodwill and intangible assets.

Cash Flow

For the first quarter of fiscal 2024, the company reported a net cash change of $789K, resulting in an ending cash balance of $3.98M. Despite a net income loss of $2.7M, strategic investments and financing activities, including a private placement grossing $4.5M, contributed positively to cash flow.

Business Developments and Strategy

Streamline Health Solutions continues to innovate in AI and automation, enhancing product functionality and client services. The AI model for revenue cycle management has already shown significant impact, enhancing coding accuracy and financial outcomes for clients. The company also emphasized its strategic partnerships, particularly with Oracle, which have shown positive traction in driving new client acquisitions and revenue growth.

Management highlighted successful client implementations that provided substantial financial impacts. One example included a 700-bed hospital seeing $1M of impact in one quarter.

Financial Ratios and Market Comparisons

The company’s Altman Z Score of -3.40 indicates a level of financial distress when compared to its peers. The current market cap is $31.99M with a total working capital of -$3.11M.

Streamline Health Solutions exhibited lower operating and net profit margins compared to industry standards, with metrics like gross profit margin at 51.22%, operating profit margin at -87.48%, and net profit margin at -85.83%. The company’s return on equity stood at -85.25%, contrasting sharply with a peer average of 5.56%.

In liquidity analysis, the current ratio was 0.75, and the quick ratio was 0.70, both lower than the industry averages, suggesting potential liquidity challenges. The company's debt-equity ratio was 51.08%, indicative of a moderate leverage position compared to peers.

Outlook

Looking ahead, Streamline Health Solutions Inc. plans to drive revenue growth through continued client acquisition and product innovation, leveraging AI and automation in its service offerings. Management anticipates revenue growth on relatively static expenses and aims to achieve persistent positive adjusted EBITDA in the second half of fiscal 2024.

For additional information, you can review the complete earnings announcement on the company’s website or through the SEC’s official filing.

Revenues Q1 - 2024

Revenue Gross Profit Operating Expenses Interest Expense EBITDA Net Income EPS
$4.33M $2.24M $3.73M $465 000 $-371 000 $-2.74M $-0.0470

Balance Q1 - 2024

Net IncomeDepreciation and AmortizationStock Based CompensationChange in Working CapitalNet Cash Provided by Operating ActivitiesCapital ExpenditureFree Cash Flow
$-2.74M$1.12M$499 000$-255 000$-1.20M$-232 000$-1.43M

Other Reports

Symbol Period Year Title
CRDO FY 2024 Credo Technology Group Holding Ltd - Fiscal Year 2024 Fourth Quarter and Year-End Earnings Report
INFY FY 2023 Infosys Limited Earnings Report for Q4 and FY '24
CRDO Q4 2024 Credo Technology Group Holding Ltd - Fiscal 2024 Fourth Quarter and Year-End Financial Report
SCS Q1 2025 Steelcase Inc. Q1 FY 2025 Financial Report
GME Q1 2024 GameStop Corp (GME) Q1 2024 Financial Results
VTGN FY 2024 VistaGen Therapeutics Inc Financial Report - Fiscal Year-End 2024
PKE FY 2024 Park Aerospace Corp. - Fourth Quarter Fiscal Year 2024 Earnings Report
PETS FY 2024 PetMed Express Q4 Fiscal Year 2024 Financial Results
ZDGE Q3 2024 Zedge Inc. Q3 2024 Financial Report
MINDP Q1 2025 Financial Report: Mitcham Industries Inc. Q1 2025 Performance Analysis
MIND Q1 2025 Mitcham Industries Inc. (MIND) - Q1 Fiscal 2025 Financial Results
CODA Q2 2024 Coda Octopus Group Inc: Second Quarter 2024 Financial Report
ORCL FY 2024 Oracle Corp Q4 2024 Financial Report
MPAA FY 2024 Motorcar Parts of America Inc. FY 2024 Financial Results
CASY FY 2024 Q4 FY2024 Financial Results - Casey’s General Stores Inc
ORCL Q4 2024 Oracle Corp Fourth Quarter and Fiscal Year 2024 Earnings Report
IOT Q1 2025 Samsara Inc. (NYSE: IOT) Q1 Fiscal 2025 Earnings Report
STRM Q1 2024 Streamline Health Solutions Inc: First Quarter of Fiscal 2024 Financial Results
SMID Q1 2024 Smith-Midland Corporation Q1 2024 Financial Results
PKE Q4 2024 Park Aerospace Corp. Q4 Fiscal 2024 Financial Report
PETS Q4 2024 PetMed Express Inc. Q4 FY2024 Financial Results
MPAA Q4 2024 Motorcar Parts of America Inc. Fiscal Year 2024 Financial Report
CAL Q1 2024 Caleres Inc. First Quarter 2024 Financial Results
FCELB Q2 2024 FuelCell Energy, Inc. (FCELB) Q2 2024 Financial Results
FCEL Q2 2024 FuelCell Energy Inc: Q2 FY2024 Financial Results
CVGW Q2 2024 Calavo Growers Inc - Q2 2024 Financial Results
SKIL Q1 2025 Q1 2025 Financial Results for Skillsoft Corp.
SCVL Q1 2024 Shoe Carnival, Inc. Q1 2023 Fiscal Report
AZO Q3 2024 AutoZone Inc. 2024 Q3 Financial Results
GHM FY 2023 Graham Corporation's Fourth Quarter Fiscal Year 2024 Financial Results
GHM Q4 2023 Graham Corporation's Fourth Quarter 2023 Financial Results
AGX Q1 2025 Argan, Inc. Q1 FY2025 Financial Results
LAKE Q1 2025 Lakeland Industries Inc. Announces Fiscal 2025 First Quarter Financial Results
COST Q3 2024 Costco Wholesale Corporation Q3 2024 Financial Report
CPB Q3 2024 Campbell Soup Co Q3 Fiscal 2024 Financial Report
SRRE FY 2023 Sunrise Real Estate Group, Inc. Financial Results - FY 2023
SMTC Q1 2025 Financial Results for Semtech Corp (SMTC) - Q1 2025
SMAR Q1 2025 Financial Results for Smartsheet Inc - Q1 2025
CXM Q1 2025 Sprinklr, Inc. Q1 2025 Financial Report
CHPT Q1 2025 Switchback Energy Acquisition Corporation (CHPT) Q1 2024 Financial Results
BBWI Q1 2024 Bath & Body Works Q1 2024 Financial Report
VRNT Q1 2025 Financial Results Q1 FY25 for Verint Systems Inc. (NASDAQ: VRNT)
CRWD Q1 2025 CrowdStrike Holdings Inc. Q1 Fiscal Year 2025 Financial Results
VEEV Q1 2025 Veeva Systems Inc. Fiscal 2025 Q1 Financial Results
VEEV Q1 2025 Veeva Systems Inc Reports Fiscal 2025 First Quarter Results
HQY Q1 2025 HealthEquity Inc. Q1 Fiscal Year 2025 Earnings Report
GTLB Q1 2025 GitLab Inc. Financial Results for the First Quarter of Fiscal Year 2025
BURL Q1 2024 Burlington Stores Inc. Q1 2024 Financial Report
LGF-B Q4 2024 Lions Gate Entertainment Corp. FY 2024 Financial Results
RSVRW FY 2023 Reservoir Media, Inc. Financial Results for Q4 2023